Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05016765 · ClinicalTrials.gov registry record · NA

Open-label MNS for Tourette Syndrome

A NA study of Tourette Syndrome and Tic Disorder, Chronic Motor or Vocal, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT05016765 is a NA study of Tourette Syndrome and Tic Disorder, Chronic Motor or Vocal that has completed, run by Washington University School of Medicine. The registered enrollment target is 31 participants, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05016765, a NA study of Tourette Syndrome and Tic Disorder, Chronic Motor or Vocal, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

A recent report (Morera Maiquez et al 2020) described reduced tic severity in people with Tourette syndrome during 1-minute epochs of median nerve stimulation (MNS) at 10 Hz. Among the various questions still to be answered is the question of whether a device to administer MNS is practical for use in a chronic, real-world setting. This study will recruit participants who complete the clinic-based, blinded, randomized controlled trial, https://clinicaltrials.gov/ct2/show/NCT04731714, to determine the real-world usage and apparent utility of median nerve stimulation in people with chronic tics.

Interventions

  • DEVICE Active, self-directed electrical stimulation of the median nerve

Study Locations (1)

Missouri

  • Washington University School of Medicine, Movement Disorders Center - St Louis

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2021-11-18
Est. Completion 2022-04-27
Phase NA

What the Registry Record Tells You About NCT05016765

The ClinicalTrials.gov registry entry for NCT05016765 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (64% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Active, self-directed electrical stimulation of the median nerve is the first listed.

NCT05016765 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT05016765 about?

NCT05016765 is a clinical study titled "Open-label MNS for Tourette Syndrome". A recent report (Morera Maiquez et al 2020) described reduced tic severity in people with Tourette syndrome during 1-minute epochs of median nerve stimulation (MNS) at 10 Hz. Among the various questions still to be answered is the question of whether a device to administer MNS is practical for use i...

What is the current status of trial NCT05016765?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2021-11-18. Estimated completion is 2022-04-27.

What conditions does trial NCT05016765 study?

This clinical trial studies the following conditions: Tourette Syndrome, Tic Disorder, Chronic Motor or Vocal.

What interventions are being tested in trial NCT05016765?

The interventions under investigation include: Active, self-directed electrical stimulation of the median nerve (DEVICE).

Who is sponsoring clinical trial NCT05016765?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05016765 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.